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Background: Up to half of all new HIV cases in Los Angeles may be caused by the 20-30% of men who have sex
with men (MSM) with unrecognized HIV infection. Racial/ethnic minority MSM are at particularly high risk for being
sero-unaware and due to stigma and poor healthcare access might benefit from novel private, self-testing methods,
such as the recently FDA-approved OraQuick® In-Home HIV Test.
Methods: From July-November 2013, we undertook a pilot study to examine the feasibility of a voucher program
for free OraQuick® tests targeting African American MSM in Los Angeles. We determined feasibility based on: (1) the
establishment of a voucher redemption and third-party payment system, (2) the willingness of community-based
organizations (CBOs) to disseminate vouchers, and (3) the collection of user demographics, test and linkage-to-care
results with an anonymous telephone survey.
Results: We partnered with Walgreens® to create a voucher and third-party reimbursement system for free OraQuick®
tests. Voucher distribution was divided into two periods. In total, 641 vouchers were supplied to CBOs: 274 (42.7%) went
to clients and of those 53 (19.3%) were redeemed. Fifty (18.2%) of the 274 clients were surveyed: 44 (88%) were African
American, 39 (78%) reported being likely to repeat voucher use, 44 (88%) reported reviewing pre-test information, and
37 (74%) the post-test information. Three (6%) of 50 survey respondents reported newly testing HIV-positive of whom
all (100%) reported seeking medical care. Two withheld their results, both of whom also sought medical care.
Conclusions: Developing and partnering with a commercial pharmacy to institute a voucher system to facilitate HIV
self-testing with linkage-to-care was feasible. Our findings suggest the voucher program was associated with increasing
the identification of new cases of HIV infection with high rates of linkage to care. Expanded research and evaluation of
voucher programs for HIV self-test kits among high-risk groups is warranted.
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The burden of HIV infection is particularly high among
men who have sex with men (MSM) in Los Angeles
(LA) County. In 2011, there were 36,330 MSM living
with HIV/AIDS and in LA County, 10,833 of which were
unaware of their infection [1]. That population dispro-
portionately includes African Americans, who are the
most vulnerable demographic group affected by HIV* Correspondence: rmarlin@mednet.ucla.edu
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unless otherwise stated.infection. In 2011, African Americans had the highest
rate of infections for any demographic group at 966 per
100,000 persons in LA [2]. In addition, African American
MSM in LA are 4 times more likely than white MSM not
to know they are infected with HIV [3].
A recent study examined HIV testing preferences
among high risk MSM in LA and found that, of 75
MSM surveyed, an in-home, immediate, and free HIV
test had the highest acceptability [4]. In 2012, the FDA
approved the OraQuick® In-Home HIV test, which al-
lows for private, rapid self-testing at home, and helps to
overcome stigma, which is a major barrier to testing.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 HIV in-home self-test voucher use survey
participant characteristics Los Angeles, 2013
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African American MSM community [5,6], and research
has shown that stigma reduces people’s willingness to test
for diseases such as HIV/AIDS [5-7]. New in-home HIV
testing methods may further reduce barriers due to
stigma that are associated with conventional provider-
based testing by making the testing experience private
and self-controlled [8]. We examined the feasibility
of piloting a commercial voucher program for free
OraQuick® In-Home HIV Test kits targeting high-risk
African American MSM in LA.Other 3 (6%)
Sexual Behavior and Gender Identification:
Men who have sex with women 1 (2%)
Women who have sex with men 9 (18%)
Men who have sex with men 33 (66%)
Women who have sex with women 2 (4%)
Transwomen 5 (10%)
Number of New Sex Partners, Past 12 Months:
0 to 1 17 (34%)
2 to 3 6 (12%)
3 to 4 13 (26%)
5+ 14 (28%)
Condom Use:
Every time 13 (26%)
Frequently or usually 29 (48%)
Sometimes or less 8 (16%)
Last HIV Test:
3 months or less 10 (20%)
3-6 months 7 (14%)
6-9 months 10 (20%)
9-12 months 8 (16%)
12+ months 15 (30%)
Voucher Redemptions:
Redeemed 49 (98%)
Did not redeem 1 (2%)
Survey Response




Not disclosed 2** (4.1%)
Activities Before Taking the Test:
Read product information or instructions 44 (89.9%)
Activities After Taking the Test:
Read product information or instructions 37 (75.5%)
*All 3 reported linkage to care.
**Both reported linkage to care.Methods
We determined feasibility of our pilot program based
on the ability to: (1) establish a functional commercial
voucher redemption and third-party payment system,
(2) use community-based organizations (CBOs) to dis-
seminate vouchers, and (3) collect and analyze data from
an anonymous telephone survey on user demographics,
sexual behavior, prior testing practices, self-testing experi-
ence, results disclosure and linkage-to-care. Due to the
very low cost of printing paper vouchers, we supplied a
large number of vouchers to CBOs for a broad reaching
campaign.
We partnered with three local CBOs servicing African
American MSM to distribute vouchers. We created double-
sided color vouchers for a free OraQuick® In-Home HIV
test, each costing < $1 to print. Each voucher had a unique
number that allowed us to track where it was distributed
and where and when it was redeemed. The vouchers were
redeemable at 12 local Walgreens, a US-based pharmacy
chain, using a third party payment system. On a monthly
basis, Walgreens invoiced our program at UCLA for
payment based on the negotiated cost and number of
redeemed vouchers. We supplied 237 vouchers to dis-
tributors in July 2013 during our first test period. During a
second test period from August through December 2013,
we supplied 404 vouchers with an attached survey recruit-
ment flyer that invited participants to contact us by
telephone.
Eligible survey participants had to be over 18 years of
age and have received a voucher from the second test
period. After obtaining informed consent, the interviewer
collected participant demographic information, HIV testing
history, sexual history, test result, linkage-to-care outcome
and experience with the voucher program. At the conc-
lusion of the interview, the participant was compensated
with a $75 gift card.
Survey data were encoded using SurveyMonkey and
descriptive frequencies were analyzed with Microsoft
Excel® and STATA® 13 (StataCorp, College Station, TX).
The UCLA institutional review board approved all aspects
of the project (IRB#13-000790).
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Voucher dissemination
Distributors confirmed that 62 of 237 (26.2%) vouchers
supplied during the first test period in July 2013 were
distributed. Ten (16.1%) of 62 distributed vouchers were
redeemed. During the second test period from August
through December 2013, 230 of 404 (56.9%) vouchers were
distributed. Forty-three (18.7%) of the distributed vouchers
were redeemed. Fifty of 230 voucher recipients (21.7%)
responded to our attached survey recruitment flyers.
CBOs employed different strategies in distributing
their supplied vouchers. One CBO supplied a total of
144 vouchers during both phases, of which 144 (100%)
were distributed and 34 were redeemed (23.6%). Vouchers
were distributed at the CBO during community meetings
and events, usually after a group discussion on self-testing.
A second CBO used a similar strategy, distributing 25 of
their 100 vouchers (25%) during both phases, 9 of which
were redeemed (9%). The third CBO was supplied 250
vouchers during both phases but only distributed 11 (4.4%),
of which none were redeemed. Their vouchers were given
to those passing by various mobile outreach vans in Los
Angeles. An additional 147 were supplied to student volun-
teers while exploring alternative distribution strategies, 35
of which were distributed (24.3%) and 10 of which (6.8%)
were redeemed. All CBOs and volunteers were asked to tar-
get their distribution toward African American MSM but
to distribute vouchers to any who were interested.Survey results
Survey respondents (n = 50) were young (90% under
35 years of age), primarily African American (88%), and
a majority MSM (66%) (Table 1). Forty-nine of 50 survey
respondents (98%) redeemed their voucher and used the
HIV in-home self-test kit. Three (6.1%) of 49 reported a
new positive test result and being linked to care, and an
additional 2 (4.1%) did not disclose their test result but
reported attending follow-up medical care. The 1 respond-
ent who did not redeem their voucher was not asked about





Comfortable exchanging  
voucher at Walgreens 
Difficult to travel to Walgreens 
Will likely repeat voucher use 
Will seek followup testing  
or treatment if positive 
Prefer self-testing  
over clinic testing 
Agree/Strongly Agre
Figure 1 Opinions in HIV in-home self-test voucher use survey attitudso n = 49 was used to calculate descriptive statistics. For all
other survey items there were no missing data and n = 50.
Using a Likert scale, 78% of participants reported that
they were likely or very likely to use a voucher again,
65% reported that it was easy to travel to a Walgreens to
redeem their voucher and 44% preferred self-testing over
clinic based testing (26%) (Figure 1). About 22% of par-
ticipants were uncomfortable or very uncomfortable
with the in-store redemption process. One participant
noted that the Walgreens staff at the store they visited
was confused about the voucher, had to involve the store
manager, took longer than expected, and overall the in-
store process made the participant feel uncomfortable.
Discussion and conclusion
We piloted an HIV self-test voucher distribution and
redemption program for free self-test kits in partnership
with a large commercial pharmacy. The cost of the actual
voucher was low and the major cost to the program was
incurred when a voucher was redeemed. Among the
sample of those surveyed who redeemed vouchers, there
was a high proportion of newly identified cases of HIV
infection. All newly identified cases reported linkage to
care. Participants endorsed the voucher system as a means
to reduce stigma associated with HIV testing through
their qualitative and quantitative feedback.
We were able to track voucher use from the time we
supplied them to the point when clients redeemed them,
validating the functionality of our system. Many CBOs
were also willing to distribute a large number of vouchers
to African American MSM. Thus, we found it feasible
to develop a commercial voucher system with 3rd-party
reimbursement to promote HIV self-testing among high-
risk African American MSM in Los Angeles.
CBOs that distributed vouchers through their member-
ship tended to have higher distribution and redemption
rates than those who solicited those passing by. In
addition, distribution and redemption increased for these
CBOs during the second phase due to increasing utilization
of membership involvement over time. The voucher pro-










e Neutral Disagree/ Strongly Disagree 
es (N = 50), Los Angeles, 2013.
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voucher reimbursement and encouraging CBOs to distrib-
ute vouchers to high-risk persons.
Our findings suggest a high acceptability for in-home
testing among high-risk African American MSM, which is
consistent with studies of MSM testing preferences [4,9].
A recent survey examined the hypothetical acceptability
of testing at a physician’s office, individual voluntary coun-
seling and testing, couples’ HIV counseling and testing,
expedited/express testing, rapid home self-testing using an
oral fluid test, and home dried blood spot specimen self-
collection for laboratory testing [9]. Home self-testing and
physician’s office testing had the highest acceptability
across all demographic and behavioral groups [9]. How-
ever, participants typically identified multiple testing sce-
narios as highly acceptable, indicating a comprehensive
strategy that provides multiple testing options to the com-
munity may have the greatest effect on this population [9].
A mathematical modeling study by Katz et al. has dem-
onstrated that a complete replacement of clinic-based
testing with in-home testing amongst MSM in Seattle
may result in an increased HIV prevalence [10]. However,
that model doesn’t account for in-home testing being
offered as a supplement to clinic-based testing, which Katz
et al [10] and a recent editorial [11] have acknowledged
may reduce HIV prevalence. In addition, promoting in-
home testing towards groups who are untested for HIV
would decrease HIV prevalence [10,11]. Programs utilizing
vouchers to promote in-home testing as a supplement to
clinic-based testing can be used to evaluate these assertions,
but determination of the effectiveness of such programs to
decrease HIV prevalence among African American MSM
will require rigorous evaluation on a larger scale.
Our pilot project had several limitations. Firstly, there
were only 43 vouchers redeemed at Walgreens but 49
respondents reported redeeming a voucher. This could
be due to individuals completing more than one survey
or individuals incorrectly reporting their voucher re-
demption. Second, given there were 230 vouchers with
survey recruitment materials and 49 of 50 respondents
reported redeeming the voucher, there is a lack of data on
those who did not redeem their voucher. Future projects
should attempt to verify the uniqueness of each survey
participant and collect information from non-redeemers.
In addition, Walgreens stores occasionally ran out of self-
test kits during the evaluation period and awareness about
the program among the Walgreens staff was inconsistent.
However, our ability to identify those limitations indicates
the success of collecting process data for quality improve-
ment necessary to enhance the pilot program. Lastly, our
survey involved a relatively small sample size of 50, but we
believed this was sufficient to assess the acceptability of
participation and provide formative information on the
structure of the voucher system.A pilot study by Young et al. has found distributing HIV
self-testing kits through smart vending machines to be
feasible [12]. Our team plans to compare multiple
methods of increasing the availability of HIV self-test
kits such as the use of smart vending machines or the
US mail and compare those with referrals to conven-
tional site-based testing to find the best ways to increase
HIV testing and community-level HIV serostatus aware-
ness among high-risk groups. Continued innovation is ur-
gently needed to address the large number of persons
unaware of their HIV infection.
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